Dexamethasone

CAS 50-02-2 11 current records 10 historicalSmall Molecule

Who holds supplier records for Dexamethasone? 11 organisations hold a current record for Dexamethasone: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), Italy (1), United States (1), China (1) and 2 other countries (2); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Dexamethasone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dexamethasone

Reading the evidence

  • 11 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Dexamethasone expires 26 Apr 2041. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (11)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Dexamethasone. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Dexamethasone sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Dexamethasone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SYMBIOTEC PHARMALAB LIMITED IndoreIN
CEP 2023-083 - Rev 01
Dexamethasone, Micronised
Apr 2026Inspected Mar 2026
Germany
TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. TianjinCN
CEP 2020-270 - Rev 01
Dexamethasone, Process II
Dec 2025—
FARMABIOS S.p.A Gropello CairoliIT
CEP 2024-335 - Rev 00
Dexamethasone, Micronised
Sept 2025Inspected Jul 2026
Italy
SHANDONG SIRUI PHARMACEUTICAL CO., LTD. HezeCN
CEP 2024-325 - Rev 00
Dexamethasone
Jun 2025—
BHAGERIA & JAJODIA PHARMACEUTICALS PRIVATE LIMITED VapiIN
CEP 2024-138 - Rev 00
Dexamethasone
May 2025—
EUROAPI FRANCE VertolayeFR
CEP 1996-019 - Rev 09
Dexamethasone, Micronised
Apr 2024Inspected Jul 2025
France
PHARMACIA & UPJOHN COMPANY LLC KalamazooUS
R1-CEP 2000-261 - Rev 05
Dexamethasone, Micronised
Sept 2022—
CURIA SPAIN S.A.U. BoecilloES
R1-CEP 2015-182 - Rev 00
Dexamethasone isonicotinate
Oct 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (10)

Organisations whose Type II DMFs for Dexamethasone are no longer active. These show a past filing, not current supply.

Show all 10 historical records
  • HOECHST MARION ROUSSEL SA
    Inactive DMF 11587 · filed Jul 1995
  • SOCIETA ITALIANA CORTICOSTEROIDI SPA
    Inactive DMF 6030 · filed Sept 1985
  • DIOSYNTH BV
    Inactive DMF 4944 · filed Jan 1983
  • COMPANIA ESPANOLA DE SINTESIS QUIMICA SA
    Inactive DMF 4497 · filed Mar 1982
  • CYCLO PRODUCTS INC
    Inactive DMF 3733 · filed Feb 1980
  • BLASCHIM SPA
    Inactive DMF 3686 · filed Jan 1980
  • United States · Inactive DMF 2816, 519, 542 · filed Dec 1976
  • ROUSSEL CORP
    Inactive DMF 2737 · filed Jul 1976
  • Brazil · Inactive DMF 2205 · filed Dec 1973
  • SF DURST AND CO INC
    Inactive DMF 1095 · filed Nov 1967

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (75 listed products contain Dexamethasone). The latest listed patent expires 26 Apr 2041. The latest listed exclusivity runs to 7 Apr 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Dexamethasone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL384467).

Chemical identity

IUPAC name
(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
Canonical SMILES
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C
InChIKey
UREBDLICKHMUKA-CXSFZGCWSA-N
Synonyms
Aeroseb-dex, Decaderm, Decadron, Decadron-75, Decaspray, Dexacortal, Dexacortin, Dexacortisyl, Dexafree, Dexametasona, Dexamethasone, Dexamethasone component of ciprodex

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Corticosteroid
Mechanism of action
Corticosteroid Hormone Receptor Agonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Dexamethasone?

11 organisations hold an active US FDA Type II Drug Master File or a CEP for Dexamethasone: Farmabios S.p.A. (Italy), Pharmacia & Upjohn, Inc. (United States), TIANJIN TIANYAO PHARMACEUTICALS CO LTD (China), EUROAPI FRANCE (France), SHANDONG SIRUI PHARMACEUTICAL CO LTD, SYMBIOTEC PHARMALAB PRIVATE LTD (India), MAHIMA LIFE SCIENCES PRIVATE LTD (India) and XIAN GUOKANG RUIJIN PHARMACEUTICAL CO LTD, and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Dexamethasone Drug Master Files are active?

Farmabios S.p.A. (DMF 31532, 43509), Pharmacia & Upjohn, Inc. (DMF 4524, 4532), TIANJIN TIANYAO PHARMACEUTICALS CO LTD (DMF 34810, 17141), EUROAPI FRANCE (DMF 1748), SHANDONG SIRUI PHARMACEUTICAL CO LTD (DMF 36894), SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 38162), MAHIMA LIFE SCIENCES PRIVATE LTD (DMF 27888) and XIAN GUOKANG RUIJIN PHARMACEUTICAL CO LTD (DMF 36270) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Dexamethasone records mean?

10 organisations have only inactive Type II DMFs for Dexamethasone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Dexamethasone have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Dexamethasone on the EDQM register, including SYMBIOTEC PHARMALAB LIMITED Indore (IN), TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin (CN), FARMABIOS S.p.A Gropello Cairoli (IT), SHANDONG SIRUI PHARMACEUTICAL CO., LTD. Heze (CN), BHAGERIA & JAJODIA PHARMACEUTICALS PRIVATE LIMITED Vapi (IN) and EUROAPI FRANCE Vertolaye (FR) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Dexamethasone?

Yes. The latest patent listed for an approved US product containing Dexamethasone expires 26 Apr 2041, across 75 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Dexamethasone supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Dexamethasone?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.